Andrea Bauer,Heinrich Dickel,Thilo Jakob et al.
Andrea Bauer et al.
Background: Chronic urticaria (CU) is a common disease which represents a considerable burden for many patients. The current urticaria guideline describes the evidence-based diagnosis and treatment of CU. In addition, how...
Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA) [0.03%]
德国变态反应协会关于辉瑞/BioNTech新冠疫苗接种后严重过敏反应的立场声明：德国变态反应医学会(AeDA)，德国变应学与临床免疫学会(DGAKI)和环境医学学会(GPA)
Ludger Klimek,Natalija Novak,Eckard Hamelmann et al.
Ludger Klimek et al.
Two employees of the National Health Service (NHS) in England developed severe allergic reactions following administration of BNT162b2 vaccine against COVID-19 (coronavirus disease 2019). The British SmPC for the BNT162b2 vaccine already in...
Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update: S2k-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Medical Association of German Allergologists (AeDA), the Society of Pediatric Allergology and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAA [0.03%]
急性过敏性反应的治疗与管理：德国变态反应和临床免疫学会(DGAKI)、德国医学变应学协会(AeDA)、儿科变态反应和环境医学学会(GPA)及德国变应原和环境医学学院(DAA)S2k指南（2021年更新）
Johannes Ring,Kirsten Beyer,Tilo Biedermann et al.
Johannes Ring et al.
Giorgio Ciprandi
Giorgio Ciprandi
Healthcare provision for insect venom allergy patients during the COVID-19 pandemic [0.03%]
COVID-19大流行期间昆虫毒液过敏患者的医疗服务保障措施
Margitta Worm,Barbara Ballmer-Weber,Randolf Brehler et al.
Margitta Worm et al.
The population prevalence of insect venom allergy ranges between 3-5%, and it can lead to potentially life-threatening allergic reactions. Patients who have experienced a systemic allergic reaction following an insect sting should be referr...
Mast cells and IgE in defense against lethality of venoms: Possible "benefit" of allergy[] [0.03%]
mast细胞和IgE在防御毒液致死性中的作用：过敏的潜在“好处”
Stephen J Galli,Martin Metz,Philipp Starkl et al.
Stephen J Galli et al.
Physicians think of mast cells and IgE primarily in the context of allergic disorders, including fatal anaphylaxis. This 'bad side' of mast cells and IgE is so well accepted that it can be difficult to think of them in other contexts, parti...
Hypersensitivity reactions to biologics (part I): allergy as an important differential diagnosis in complex immune-derived adverse events [0.03%]
生物制剂的超敏反应（上篇）：过敏是复杂免疫介导不良事件的重要鉴别诊断
Askin Gülsen,Bettina Wedi,Uta Jappe
Askin Gülsen
Purpose: Biotechnological substances (BSs) are strongly relied upon to prevent rejection of transplanted organs, and to treat oncological, allergological, and other inflammatory diseases. Allergic reactions to partly fore...
Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution? [0.03%]
呼吸道病毒引起的异源免疫：是问题的一部分还是解决方案的一部分？
Emanuel Pusch,Harald Renz,Chrysanthi Skevaki
Emanuel Pusch
Purpose: To provide current knowledge on respiratory virus-induced heterologous immunity (HI) with a focus on humoral and cellular cross-reactivity. Adaptive heterologous immune responses have broad implications on infect...
Comparison of sublingual immunotherapy and oral immunotherapy in peanut allergy [0.03%]
舌下免疫疗法和口服免疫疗法在花生过敏中的比较研究
Wenming Zhang,Sayantani B Sindher,Vanitha Sampath et al.
Wenming Zhang et al.
The prevalence of food allergy has been increasing over the past few decades at an alarming rate with peanut allergy affecting about 2% of children. Both oral immunotherapy (OIT) and sublingual immunotherapy (SLIT) have shown promise as a t...